IDEXX Laboratories Inc (IDXX)
418.55
-0.06
(-0.01%)
USD |
NASDAQ |
Nov 21, 16:00
428.99
+10.44
(+2.49%)
After-Hours: 04:58
IDEXX Laboratories Enterprise Value: 34.84B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 34.84B |
| November 20, 2024 | 34.84B |
| November 19, 2024 | 34.66B |
| November 18, 2024 | 34.94B |
| November 15, 2024 | 35.03B |
| November 14, 2024 | 35.26B |
| November 13, 2024 | 35.76B |
| November 12, 2024 | 35.46B |
| November 11, 2024 | 36.37B |
| November 08, 2024 | 36.04B |
| November 07, 2024 | 36.02B |
| November 06, 2024 | 35.24B |
| November 05, 2024 | 34.63B |
| November 04, 2024 | 34.51B |
| November 01, 2024 | 34.73B |
| October 31, 2024 | 33.89B |
| October 30, 2024 | 37.50B |
| October 29, 2024 | 37.24B |
| October 28, 2024 | 37.37B |
| October 25, 2024 | 37.60B |
| October 24, 2024 | 37.67B |
| October 23, 2024 | 38.13B |
| October 22, 2024 | 38.42B |
| October 21, 2024 | 37.76B |
| October 18, 2024 | 38.12B |
| Date | Value |
|---|---|
| October 17, 2024 | 38.30B |
| October 16, 2024 | 38.62B |
| October 15, 2024 | 39.44B |
| October 14, 2024 | 39.78B |
| October 11, 2024 | 39.64B |
| October 10, 2024 | 39.39B |
| October 09, 2024 | 39.50B |
| October 08, 2024 | 39.58B |
| October 07, 2024 | 39.32B |
| October 04, 2024 | 39.75B |
| October 03, 2024 | 40.23B |
| October 02, 2024 | 40.43B |
| October 01, 2024 | 41.21B |
| September 30, 2024 | 42.01B |
| September 27, 2024 | 42.67B |
| September 26, 2024 | 42.44B |
| September 25, 2024 | 41.51B |
| September 24, 2024 | 42.22B |
| September 23, 2024 | 42.33B |
| September 20, 2024 | 42.25B |
| September 19, 2024 | 43.10B |
| September 18, 2024 | 42.63B |
| September 17, 2024 | 42.71B |
| September 16, 2024 | 42.63B |
| September 13, 2024 | 41.74B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
16.49B
Minimum
Mar 23 2020
60.72B
Maximum
Aug 05 2021
39.62B
Average
40.66B
Median
Apr 05 2023
Enterprise Value Benchmarks
| Agilent Technologies Inc | 39.10B |
| Bio-Rad Laboratories Inc | 8.694B |
| Regeneron Pharmaceuticals Inc | 74.00B |
| West Pharmaceutical Services Inc | 22.95B |
| NovaBay Pharmaceuticals Inc | 2.798M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 232.84M |
| Revenue (Quarterly) | 975.54M |
| Total Expenses (Quarterly) | 671.65M |
| EPS Diluted (Quarterly) | 2.80 |
| Gross Profit Margin (Quarterly) | 61.10% |
| Profit Margin (Quarterly) | 23.87% |
| Earnings Yield | 2.48% |
| Operating Earnings Yield | 3.18% |
| Normalized Earnings Yield | 2.478 |